Zenas BioPharma, Inc. (ZBIO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.62B |
| Enterprise Value | 1.59B |
| P/E Ratio | -3.36 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 2,038.58 |
| Price/Book Ratio | 8.25 |
| Enterprise/Revenue | 2,065.8 |
| Enterprise/EBITDA | -4.52 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -484.38 |
| Operating Margin | -475.57 |
| Return On Assets | -0.69 |
| Return On Equity | -1.9 |
| Revenue | 10M |
| Revenue/Share | 0.02 |
| Gross Profit | 10M |
| EBITDA | -370.43M |
| Net Income | -377.74M |
| Diluted EPS | -8.44 |
| Total Cash | 643.13M |
| Total Cash/Share | 10.19 |
| Total Debt | 223.8M |
| Total Debt/Equity | 0.91 |
| Current Ratio | 9.93 |
| Book Value Per Share | 3.92 |
| 52-Week Change | 94.99 |
| 52-Week High | 44.6 |
| 52-Week Low | 13.5 |
| Moving Average 50 Days | 28.08 |
| Moving Average 200 Days | 26.05 |
| Average Volume | 849,941 |
| Shares Outstanding | 63.13M |
| % Held by Institutions | 110.64 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |